drugset / Trial / NCT00215423
Study in Patients With COPD
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug
Timeline
- Start
- —
- Primary completion
- 2003-12
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 2.5 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 5 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 10 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 20 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 40 ug | Inhaled |